Hoth Therapeutics, Inc. — Director's Dealing 2022

Dec 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2022-12-13

Reporting Person: Pavell Jeff (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-13	Common Stock	A	5075	—	Acquired	5075	Direct

Footnotes

F1: Issued for services as a member of the Issuer's Board of Directors.

F2: The common stock was issued pursuant to the Issuer's 2018 Equity Incentive Plan and shall vest in three equal annual installments, with the first installment vesting on the date of grant.